TrialAlzheimer's research & therapy2022

Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer's dementia in mild cognitive impairment patients.

Alexa Pichet Binette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.